Valdosta Daily Times

Top News

October 24, 2012

Roche investigated for not reporting side effects

LONDON — Europe’s top drug regulator announced Tuesday it is taking action against pharmaceutical giant Roche for allegedly failing to properly report the side effects of 19 drugs being used by U.S. patients.

It is the first time the European Medicines Agency has begun a so-called ‘infringement proceeding’ against a drug maker. European regulations lay out numerous requirements for pharmaceuticals, including reporting suspected side effects and submitting such cases to officials.

Eight of the drugs involved are used for the treatment of cancer, including breast cancer. They include Avastin, Herceptin, Tarceva, and Xeloda. The flu drug Tamiflu was also included in the list.

British authorities brought the problem to the attention of the European authorities in May after noticing “serious shortcomings” in how Roche AG reported potential side effects.

Regulators said about 80,000 reports by consumers of possible adverse effects to drugs sold in the U.S. had not been properly analyzed. Among those reports were over 15,000 deaths, though it was unclear if those deaths were caused by Roche medicines.

The regulator said there was no evidence that users of Roche’s drugs were at risk.

The European Medicines Agency did not state what the side effects were but said it was more concerned that these potential reactions were not properly reported.

“It could have been anything like a rash on your hand to something more serious,” including death, said Monika Benstetter, an agency spokeswoman. “There was a failure in the system,” she said, noting officials didn’t have information on how many of the side effects may have been reported.

If Roche is found to have violated its reporting requirements, it could be fined up to five percent of its sales revenue in the European Union from the preceding year. Shares in the company fell 2 percent on Tuesday.

The European Commission, the executive body for the 27-country EU, asked the European Medicines Agency to begin the infringement process. In a statement, the European Medicines Agency said it will further investigate the allegations against Roche.

The agency sent Roche a detailed letter listing the allegations against them and is now awaiting the company’s response. Officials have 18 months to finish their investigation. After that, it will be up to the European Commission to decide whether Roche should be penalized.

Daniel Grotzky, a Roche spokesman, said the company was working with the EMA to provide more information and it did not want to speculate on the outcome of the investigation. Roche said patient safety was “of paramount importance” and that it was possible some of the potential side effects may have been reported to European officials in other ways, such as reports from doctors.

“Both the EMA and other health authorities have consistently said there is no change to the safety profile of our drugs,” Grotzky said.

He said Roche recognized that some adverse events had not properly been reported in the past.

“We are taking measures within the company...to make sure this does not happen again,” he said.

 

For more on this story and other local news, subscribe to The Valdosta Daily Times e-Edition, or our print edition

1
Text Only
Top News
  • Palestinian rivals to try again for unity deal

    Rival Palestinian factions Hamas and Fatah agreed Wednesday to form a unity government and hold new elections — a potentially historic step toward mending the rift that has split their people between two sets of rulers for seven years.

    April 24, 2014

  • Obama administration weighs clemency for inmates jailed for 10 years

    The Obama administration is encouraging many nonviolent federal prisoners to apply for early release — and expecting thousands to take up the offer.

    April 24, 2014

  • Earns Facebook_Stew.jpg Facebook 1Q results soar; CFO to step down

    Facebook’s earnings nearly tripled and revenue grew sharply in the first quarter, surpassing Wall Street’s expectations thanks to an 82 percent increase in advertising revenue.

    April 24, 2014 1 Photo

  • Georgia Gun Bill_Stew.jpg Gun carry rights expanded in Ga. under new law

    Criticized by one group as the “guns everywhere” bill, Georgia took a big step Wednesday toward expanding where licensed carriers can take their weapons, with the governor signing a law that allows them in bars without restriction and in some churches, schools and government buildings under certain circumstances.

    April 24, 2014 1 Photo

  • Clemson Spring Game F_Stew.jpg Clemson’s Swinney won’t change after complaint

    Clemson coach Dabo Swinney said Wednesday he wouldn’t change procedures after the Freedom From Religion Foundation’s letter of complaint expressing concerns about the football program’s connection to the coach’s Christian religion.

    April 24, 2014 1 Photo

  • Today in History

    In 1800, Congress approved a bill establishing the Library of Congress.

    April 24, 2014

  • Michigan affirmative ban is OK, Supreme Court says

    A state’s voters are free to outlaw the use of race as a factor in college admissions, the Supreme Court ruled Tuesday in a blow to affirmative action that also laid bare tensions among the justices about a continuing need for programs that address racial inequality in America.

    April 23, 2014

  • ‘Piles and piles’ of bodies in South Sudan slaughter

    Gunmen who targeted both children and the elderly left “piles and piles” of bodies — many of those in a mosque — in a provincial capital in South Sudan, the U.N.’s top humanitarian official in the country said Tuesday.

    April 23, 2014

  • Obama_Stew.jpg Obama views mudslide scene

    Swooping over a terrain of great sadness and death, President Barack Obama took an aerial tour Tuesday of the place where more than three dozen people perished in a mudslide last month, then mourned privately with those who lost loved ones in the destruction.

    April 23, 2014 1 Photo

  • Wall Street_Stew.jpg Earnings and corporate deals lift U.S. stocks

    Corporate deals and some solid earnings reports propelled the stock market to its sixth straight gain Tuesday.

    April 23, 2014 1 Photo

Top News
Poll

Given the amount of rain recently, what's your favorite “rain” song?

Singing in the Rain
Purple Rain
Have You Ever Seen the Rain?
November Rain
Rainy Night in Georgia
Other
     View Results